These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8436190)

  • 1. Cross-linking of surface IgM, but not surface IgD receptors, by soluble monoclonal antibodies primes murine B cells to secrete immunoglobulin in response to lymphokines.
    Phillips C; Klaus GG
    Eur J Immunol; 1993 Feb; 23(2):574-7. PubMed ID: 8436190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble anti-mu monoclonal antibodies prime resting B cells to secrete immunoglobulins in response to interleukins-4 and -5.
    Phillips C; Klaus GG
    Eur J Immunol; 1992 Jun; 22(6):1541-5. PubMed ID: 1601040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-linking of B lymphocyte Fc gamma receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis.
    Phillips NE; Parker DC
    J Immunol; 1984 Feb; 132(2):627-32. PubMed ID: 6228594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation and proliferation signals in mouse B cells. V.A. comparison of the effects of intact (IgG) and F (ab')2 anti-mu or anti-delta antibodies.
    Klaus GG; Bijsterbosch MK; Parkhouse RM
    Immunology; 1985 Apr; 54(4):677-83. PubMed ID: 2984110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-Cell suppression in adult mice injected with anti-delta followed by anti-mu mAb.
    Chentoufi AA; Nizet Y; Havaux X; Nisol F; Bazin H; Latinne D
    Cell Immunol; 2000 Oct; 205(1):40-51. PubMed ID: 11078606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of neonatal anti-delta antibody treatment on the murine immune system. I. Suppression of development of surface IgD+ B cells and expansion of a surface IgM+ IgD- B lymphocyte population.
    Finkelman FD; Mond JJ; Metcalf ES
    J Immunol; 1983 Aug; 131(2):593-600. PubMed ID: 6602840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40.
    Parry SL; Hasbold J; Holman M; Klaus GG
    J Immunol; 1994 Mar; 152(6):2821-9. PubMed ID: 7511629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell tolerance induction by cross-linking of membrane IgM, but not IgD, and synergy by cross-linking of both isotypes.
    Gaur A; Yao XR; Scott DW
    J Immunol; 1993 Mar; 150(5):1663-9. PubMed ID: 8436810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
    Maruyama S; Kubagawa H; Cooper MD
    J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. Effects of B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma.
    Udhayakumar V; Kumar L; Subbarao B
    J Immunol; 1991 Jun; 146(12):4120-9. PubMed ID: 2040794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between lymphocyte membrane molecules. II. Characterization of an interaction between B lymphocyte surface IgD and Fc IgG receptors that differs from the surface IgM-Fc IgG receptor interaction.
    Dickler HB; Kubicek MT; Finkelman FD
    J Immunol; 1982 Mar; 128(3):1271-7. PubMed ID: 6799572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression, distribution and specificity of Fc receptors for IgM on murine B cells.
    Mathur A; Lynch RG; Köhler G
    J Immunol; 1988 Sep; 141(6):1855-62. PubMed ID: 2971716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo B lymphocyte-activating properties of monoclonal anti-delta antibodies. I. Determinants of B lymphocyte-activating properties.
    Goroff DK; Stall A; Mond JJ; Finkelman FD
    J Immunol; 1986 Apr; 136(7):2382-92. PubMed ID: 2419432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synergistic effects of anti-IgM and monoclonal anti-Ia antibodies in induction of murine B lymphocyte activation.
    Baluyut AR; Subbarao B
    J Mol Cell Immunol; 1988; 4(1):45-57. PubMed ID: 3266924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of lipopolysaccharide-induced activation of immature B cells by anti-mu and anti-delta antibodies and its modulation by interleukin-4.
    Brines RD; Klaus GG
    Int Immunol; 1992 Jul; 4(7):765-71. PubMed ID: 1498086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The selective role of membrane IgG in the antigen-induced inhibition of human in vitro antibody synthesis.
    Stevens RH; Benveniste E; Pineda E
    J Immunol; 1982 Jan; 128(1):398-401. PubMed ID: 6798112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-3 and granulocyte-macrophage colony-stimulating factor strongly induce Ig secretion by sort-purified murine B cell activated through the membrane Ig, but not the CD40, signaling pathway.
    Snapper CM; Moorman MA; Rosas FR; Kehry MR; Maliszewski CR; Mond JJ
    J Immunol; 1995 Jun; 154(11):5842-50. PubMed ID: 7538533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of human B cell proliferation through surface Bp35 (CD20) polypeptides or immunoglobulin receptors.
    Clark EA; Shu G
    J Immunol; 1987 Feb; 138(3):720-5. PubMed ID: 3492530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of a monoclonal anti-mu chain antiserum on the in vitro growth of normal B cells.
    Boyd AW; Pike BL
    Eur J Immunol; 1982 Mar; 12(3):184-8. PubMed ID: 6807696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of immunoglobulin receptors and T cell mediators in B lymphocyte activation. I. B cell activation by anti-immunoglobulin and anti-idiotype reagents.
    Primi D; Lewis GK; Goodman JW
    J Immunol; 1980 Sep; 125(3):1286-92. PubMed ID: 6774015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.